Gladstone NOW: The Campaign Join Us on the Journey✕
On February 8, 2021, Gladstone Institutes and the Center for iPS Cell Research and Application (CiRA) at Kyoto University held a Kickoff Symposium for the iPS Cell Research Center at Gladstone Institutes. The iPS Cell Research Center at Gladstone Institutes was created in 2019 to promote disruptive, borderless innovation through advanced biomedical research using iPS cells.
Watch the presentations from the symposium.
Deepak Srivastava, MD, President, Gladstone Institutes
Nagahiro Minato, MD, PhD, President, Kyoto University
Toru Kawamura, PhD, Head of Director’s Office and Specially Appointed Professor, CiRA, Kyoto University
Shinya Yamanaka, MD, PhD, Senior Investigator, Gladstone Institutes; Director and Professor, CiRA, Kyoto University
Kiichiro Tomoda, PhD, Research Investigator, Gladstone Institutes; Program-Specific Research Center Associate Professor, CiRA, Kyoto University
Todd McDevitt, PhD, Senior Investigator, Gladstone Institutes
Kazuo Takayama, PhD, Junior Associate Professor, CiRA, Kyoto University
Benoit Bruneau, PhD, Director, Gladstone Institute of Cardiovascular Disease
Shinya Yamanaka, MD, PhD, Senior Investigator, Gladstone Institutes; Director and Professor, CiRA, Kyoto University
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Among his myriad accomplishments, Rudolf Jaenisch—winner of the 2025 Ogawa-Yamanaka Stem Cell Prize—was the first to demonstrate the potential of induced pluripotent stem cells to treat disease.
Awards Ogawa Stem Cell Prize Profile Regenerative Medicine Stem Cells/iPSCsSrivastava will present at the American Heart Association’s Scientific Sessions 2025 in New Orleans; the lectureship is a major recognition of excellence by the association.
News Release Cardiovascular Disease Srivastava Lab Genomics Stem Cells/iPSCsIn this video, Gladstone scientists share how they used stem cells, gene editing, and AI to identify a gene driving heart defects in Down syndrome—and how reducing its levels in mice restored normal heart development, offering hope for future treatments
Gladstone Experts Cardiovascular Disease Data Science and Biotechnology Pollard Lab Srivastava Lab AI Big Data CRISPR/Gene Editing Human Genetics Stem Cells/iPSCs